Exit

Health Condition

Chronic Candidiasis

The right diet is the key to managing many diseases and to improving general quality of life. For this condition, scientific research has found benefit in the following healthy eating tips.

  • Yogurt

    Yogurt that contains Lactobacillus acidophilus has been reported to have a therapeutic effect in women with vaginal infections caused by Candida.
    Yogurt
    ×

    Yogurt that contains Lactobacillus acidophilus has been reported to have a therapeutic effect in women with vaginal infections caused by Candida.

  • Foods with Yeast and Mold

    Eliminating these types of foods, which contain yeast and mold, may reduce possible reactions due to sensitivities.
    Foods with Yeast and Mold
    ×

    Based on their clinical experience and on very preliminary research, several doctors have suggested that certain dietary factors may promote the overgrowth of Candida albicans. The most important of these factors are high intakes of sugar, milk, and other dairy products; foods with a high content of yeast or mold (e.g., alcoholic beverages, cheeses, dried fruits, and peanuts); and foods to which individual patients are allergic. However, few clinical trials have investigated whether these dietary factors affect people with conditions for which Candida is the causative agent.

  • Low-Sugar

    Choose whole grains and unprocessed foods over white flour, refined sugars, and fruit juices that may help yeast grow in the intestine.
    Low-Sugar
    ×

    One study compared levels of various sugars in urine of healthy women with levels found in women with chronic vaginal Candida infections.50 Urine sugar levels correlated with dietary intakes of sugar, dairy, and artificial sweeteners. Among women who reduced their intake of sugar, 90% reported no vaginal yeast infections during the following year. These researchers reported a “dramatic reduction” in the incidence and severity of vaginitis caused by Candida as a result of reducing intake of dairy, sugar, and artificial sweeteners.

    Many apparently healthy people have some Candida in their gastrointestinal tract. In one trial, high-sugar diets given to healthy people had mixed effects on the concentration of Candida found in their stool, though some subjects did show an increase in Candida after eating more sugar.51 These preliminary reports suggest, but do not prove, that diet might affect the ability of Candida to infect the body.

References

1. Truss CO. The role of Candida albicans in human illness. J Orthomol Psychiatry 1981,10:228-38 [review].

2. Crook WG. The Yeast Connection, 2nd ed. Jackson, TN: Professional Books, 1984, 1-2 [review].

3. Kroker GF. Chronic candidiasis and allergy. In: Brostoff J, Challacombe SJ (eds). Food Allergy and Intolerance. Philadelphia, PA: WB Saunders, 1987, 850-72 [review].

4. Bauman DS, Hagglund HE. Correlation between certain polysystem chronic complaints and an enzyme immunoassay with antigens of Candida albicans. J Advancement Med 1991;4:5-19.

5. Bennett JE. Candidiasis. In: Fauci AS, Braunwald E, Isselbacher KJ, et al (eds). Harrison's Principles of Internal Medicine New York: McGraw-Hill, 1998.

6. Hahn FE, Ciak J. Berberine. Antibiotics 1976;3:577-88 [review].

7. Mahajan VM, Sharma A, Rattan A. Antimycotic activity of berberine sulphate: an alkaloid from an Indian medicinal herb. Sabouraudia 1982;20:79-81.

8. Bhakat MP. Therapeutic trial of Berberine sulphate in non-specific gastroenteritis. Indian Med J 1974;68:19-23.

9. Kamat SA. Clinical trial with berberine hydrochloride for the control of diarrhoea in acute gastroenteritis. J Assoc Physicians India 1967;15:525-9.

10. Desai AB, Shah KM, Shah DM. Berberine in the treatment of diarrhoea. Indian Pediatr 1971;8:462-5.

11. Boero M, Pera A, Andriulli A, et al. Candida overgrowth in gastric juice of peptic ulcer subjects on short- and long-term treatment with H2-receptor antagonists. Digestion 1983;28:158-63.

12. Rubinstein E. Antibacterial activity of the pancreatic fluid. Gastroenterology 1985;88:927-32 [review].

13. Sarker SA, Gyr R. Non-immunological defense mechanisms of the gut. Gut 1990;33:1331-7 [review].

14. Keeney EL. Sodium caprylate: a new and effective treatment of moniliasis of the skin and mucous membrane. Bull Johns Hopkins Hosp 1946;78:333-9.

15. Neuhauser I, Gustus EL. Successful treatment of intestinal moniliasis with fatty acid resin complex. Arch Intern Med 1954;93:53-60.

16. Boero M, Pera A, Andriulli A, et al. Candida overgrowth in gastric juice of peptic ulcer subjects on short- and long-term treatment with H2-receptor antagonists. Digestion 1983;28:158-63.

17. Rubinstein E. Antibacterial activity of the pancreatic fluid. Gastroenterology 1985;88:927-32 [review].

18. Sarker SA, Gyr R. Non-immunological defense mechanisms of the gut. Gut 1990;33:1331-7 [review].

19. Coeugniet EG, Kuhnast R. Recurrent candidiasis: adjuvant immunotherapy with different formulations of Echinacin®. Therapiewoche 1986;36:3352-8.

20. Moore GS, Atkins RD. The fungicidal and fungistatic effects of an aqueous garlic extract on medically important yeast-like fungi. Mycologia 1977;69:341-8.

21. Sandhu DK, Warraich MK, Singh S. Sensitivity of yeasts isolated from cases of vaginitis to aqueous extracts of garlic. Mykosen 1980;23:691-8.

22. Prasad G, Sharma VD. Efficacy of garlic (Allium sativum) treatment against experimental candidiasis in chicks. Br Vet J 1980;136:448-51.

23. Arora DS, Kaur J. Anti-microbial activity of spices. Int J Antimicrob Agents 1999;12:257-62.

24. Hahn FE, Ciak J. Berberine. Antibiotics 1976;3:577-88 [review].

25. Mahajan VM, Sharma A, Rattan A. Antimycotic activity of berberine sulphate: an alkaloid from an Indian medicinal herb. Sabouraudia 1982;20:79-81.

26. Bhakat MP. Therapeutic trial of Berberine sulphate in non-specific gastroenteritis. Indian Med J 1974;68:19-23.

27. Kamat SA. Clinical trial with berberine hydrochloride for the control of diarrhoea in acute gastroenteritis. J Assoc Physicians India 1967;15:525-9.

28. Desai AB, Shah KM, Shah DM. Berberine in the treatment of diarrhoea. Indian Pediatr 1971;8:462-5.

29. Hahn FE, Ciak J. Berberine. Antibiotics 1976;3:577-88 [review].

30. Mahajan VM, Sharma A, Rattan A. Antimycotic activity of berberine sulphate: an alkaloid from an Indian medicinal herb. Sabouraudia 1982;20:79-81.

31. Bhakat MP. Therapeutic trial of Berberine sulphate in non-specific gastroenteritis. Indian Med J 1974;68:19-23.

32. Kamat SA. Clinical trial with berberine hydrochloride for the control of diarrhoea in acute gastroenteritis. J Assoc Physicians India 1967;15:525-9.

33. Desai AB, Shah KM, Shah DM. Berberine in the treatment of diarrhoea. Indian Pediatr 1971;8:462-5.

34. Hammer KA, Carson CF, Riley TV. In-vitro activity of essential oils, in particular Melaleuca alternafolia (tea tree) oil and tea tree oil products, against Candida albicans. J Antimicrobial Chemother 1998;42:591-5.

35. Stiles JC, Sparks W, Ronzio RA. The inhibition of Candida albicans by oregano. J Applied Nutr 1995;47:96-102.

36. Hahn FE, Ciak J. Berberine. Antibiotics 1976;3:577-88 [review].

37. Mahajan VM, Sharma A, Rattan A. Antimycotic activity of berberine sulphate: an alkaloid from an Indian medicinal herb. Sabouraudia 1982;20:79-81.

38. Bhakat MP. Therapeutic trial of Berberine sulphate in non-specific gastroenteritis. Indian Med J 1974;68:19-23.

39. Kamat SA. Clinical trial with berberine hydrochloride for the control of diarrhoea in acute gastroenteritis. J Assoc Physicians India 1967;15:525-9.

40. Desai AB, Shah KM, Shah DM. Berberine in the treatment of diarrhoea. Indian Pediatr 1971;8:462-5.

41. Hammer KA, Carson CF, Riley TV. In-vitro activity of essential oils, in particular Melaleuca alternafolia (tea tree) oil and tea tree oil products, against Candida albicans. J Antimicrobial Chemother 1998;42:591-5.

42. Stiles JC, Sparks W, Ronzio RA. The inhibition of Candida albicans by oregano. J Applied Nutr 1995;47:96-102.

43. Collins EB, Hardt P. Inhibition of Candida albicans by Lactobacillus acidophilus. J Dairy Sci 1980;63:830-2.

44. Fitzsimmons N, Berry DR. Inhibition of Candida albicans by Lactobacillus acidophilus: evidence for the involvement of a peroxidase system. Microbios 1994;80:125-33.

45. Wagner RD, Pierson C, Warner T, et al. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 1997;65(10):4165-72.

46. Hammer KA, Carson CF, Riley TV. In-vitro activity of essential oils, in particular Melaleuca alternafolia (tea tree) oil and tea tree oil products, against Candida albicans. J Antimicrobial Chemother 1998;42:591-5.

47. Stiles JC, Sparks W, Ronzio RA. The inhibition of Candida albicans by oregano. J Applied Nutr 1995;47:96-102.

48. Hammer KA, Carson CF, Riley TV. In-vitro activity of essential oils, in particular Melaleuca alternafolia (tea tree) oil and tea tree oil products, against Candida albicans. J Antimicrobial Chemother 1998;42:591-5.

49. Stiles JC, Sparks W, Ronzio RA. The inhibition of Candida albicans by oregano. J Applied Nutr 1995;47:96-102.

50. Horowitz BJ, Edelstein SW, Lippman L. Sugar chromatography studies in recurrent candida vulvovaginitis. J Reproduc Med 1984;29:441-3.

51. Weig M, Werner E, Frosch M, Kasper H. Limited effect of refined carbohydrate dietary supplementation on colonization of the gastrointestinal tract of healthy subjects by Candida albicans. Am J Clin Nutr 1999;69:1170-3.

Copyright © 2019 Healthnotes, Inc. All rights reserved. www.healthnotes.com

Learn more about Healthnotes, the company.

The information presented by Healthnotes is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. Self-treatment is not recommended for life-threatening conditions that require medical treatment under a doctor's care. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2019.